CHENYSEServices-Home Health Care ServicesFiscal year ends December 31

CHEMED CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026

$508.29−4.09 (-0.80%)

Close on Oct 19, 2026

Market cap: $6.71B
P/E (TTM): 25.5
Dividend yield: 0.43%

CHEMED CORP income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	2,530	2,431	2,264	2,135	2,139	2,080	1,939	1,783	1,667	1,577	1,543	1,456	1,413	1,430	1,356	1,281	1,190	1,149
Cost of Revenue	1,707	1,577	1,466	1,370	1,369	1,378	1,321	1,228	1,151	1,115	1,088	1,035	1,009	1,033	970	906	835	811
Gross Profit	823	854	799	765	770	701	617	555	516	461	456	422	405	397	385	375	356	338
Selling, General & Admin	417	424	395	359	367	330	306	271	277	244	238	223	216	209	202	202	197	175
Advertising Expenses	77	73	68	62	62	54	50	47	41	37	36	33	31	29	27	28	27	–
Operating Expenses	2,192	2,065	1,924	1,791	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Costs & Expenses	2,192	2,065	1,924	1,791	1,796	1,690	1,681	1,539	1,554	1,398	1,359	1,288	1,280	1,274	1,202	1,137	1,064	1,016
Operating Income	338	366	341	343	343	390	257	244	113	179	184	168	133	156	154	144	126	133
Interest Expense	1.75	1.78	3.11	4.58	1.87	2.36	4.54	4.99	4.27	3.72	3.65	8.19	15	15	14	12	12	12
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	0.28	-0.03	0.85	0.81	0.43	0.44	0.42	–
Other Non-Operating Income	19	35	13	-9.23	9.14	8.67	8.76	0.96	8.15	2.02	-0.69	2.52	5.47	4.12	0.72	2.27	5.87	-8.74
Merger & Restructuring Charges	–	–	–	–	–	–	–	–	–	–	–	–	–	1.13	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	-5.27	-0.42	-0.70	-0.64	-0.32	-0.35	-0.44	-0.43	-0.37	–
Pretax Income	356	399	350	330	350	396	262	240	117	177	180	163	124	146	141	134	121	115
Income Tax Expense	91	97	78	80	82	77	42	34	19	68	70	63	47	57	55	52	47	47
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	–	86	82	74	68
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.25	–
Net Income	265	302	273	250	269	319	220	206	98	109	110	99	77	89	86	82	74	67
Net Income to Common	265	302	273	250	269	319	220	206	98	109	110	99	77	89	–	–	–	–
EPS (Basic)(per share)	18.42	20.10	18.11	16.72	17.14	20.02	13.77	12.80	6.11	6.64	6.54	5.79	4.24	4.72	4.19	3.62	3.29	2.92
EPS (Diluted)(per share)	18.34	19.89	17.93	16.53	16.85	19.48	13.31	12.23	5.86	6.48	6.33	5.57	4.16	4.62	4.10	3.55	3.24	2.88
Shares Outstanding (Basic, Weighted)(shares)	14	15	15	15	16	16	16	16	16	16	17	17	18	19	21	23	22	23
Shares Outstanding (Diluted, Weighted)(shares)	14	15	15	15	16	16	17	17	17	17	17	18	19	19	21	23	23	23
Dividend per Share(per share)	2.20	1.80	1.56	1.48	1.40	1.32	1.24	1.16	1.08	1.00	0.92	0.84	0.76	0.68	0.60	0.52	0.36	0.24
EBITDA	403	430	401	403	402	446	303	282	149	213	218	199	163	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 33.1%
Operating margin: 13.5%
Net margin: 10.6%
Return on equity, FY2025: 25.3%

Financial strength

Current ratio: 0.91
Debt to equity: 0.17
Debt to assets: 8.9%
Cash to current liabilities: 12.6%

Valuation

P/E ratio: 25.5
Price to sales: 2.59
Price to book: 8.08
Dividend yield: 0.43%